APO RESEARCH · REPORT
Head Lice Infestation Drug
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Product & engineering
Understand the product.
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Selected research
Industry Growth & Trends
Global Head Lice Infestation Drug Industry Growth and Trends Forecast to 2032
Market perspective
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Head Lice Infestation Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Head Lice Infestation Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Head Lice Infestation Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Head Lice Infestation Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Head Lice Infestation Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Head Lice Infestation Drug Market by Company
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Head Lice Infestation Drug Segment by Type
Lotion
Creams
Shampoo
Other
Head Lice Infestation Drug Segment by Application
Children
Adult
Head Lice Infestation Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head Lice Infestation Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Head Lice Infestation Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head Lice Infestation Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lotion
- Creams
- Shampoo
- Other
Applications
- Children
- Adult
Companies covered
- Bayer
- Omega Pharma
- Thornton and Ross
- Prestige Brands
- Perrigo
- Actavis
- Reckitt Benckier
- Tyratech
- Shionogi
- TecLabs
- Arborpharma
- Major Pharmaceuticals
- Logic Products
- Tianren
- ParaPRO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Head Lice Infestation Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Head Lice Infestation Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Head Lice Infestation Drug Market by Type
- 1.3.1 Lotion
- 1.3.2 Creams
- 1.3.3 Shampoo
- 1.3.4 Other
- 1.4 Global Head Lice Infestation Drug Market Size by Type
- 1.4.1 Global Head Lice Infestation Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Head Lice Infestation Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Head Lice Infestation Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Head Lice Infestation Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Head Lice Infestation Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Head Lice Infestation Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Head Lice Infestation Drug Industry Trends
- 2.2 Head Lice Infestation Drug Industry Drivers
- 2.3 Head Lice Infestation Drug Industry Opportunities and Challenges
- 2.4 Head Lice Infestation Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Head Lice Infestation Drug Revenue (2021-2026)
- 3.2 Global Top Players by Head Lice Infestation Drug Sales (2021-2026)
- 3.3 Global Top Players by Head Lice Infestation Drug Price (2021-2026)
- 3.4 Global Head Lice Infestation Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Head Lice Infestation Drug Major Company Production Sites & Headquarters
- 3.6 Global Head Lice Infestation Drug Company, Product Type & Application
- 3.7 Global Head Lice Infestation Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Head Lice Infestation Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Head Lice Infestation Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Head Lice Infestation Drug Tier 1, Tier 2, and Tier 3
4 Head Lice Infestation Drug Regional Status and Outlook
- 4.1 Global Head Lice Infestation Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Head Lice Infestation Drug Historic Market Size by Region
- 4.2.1 Global Head Lice Infestation Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Head Lice Infestation Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Head Lice Infestation Drug Forecasted Market Size by Region
- 4.3.1 Global Head Lice Infestation Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Head Lice Infestation Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Head Lice Infestation Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Head Lice Infestation Drug by Application
- 5.1 Head Lice Infestation Drug Market by Application
- 5.1.1 Children
- 5.1.2 Adult
- 5.2 Global Head Lice Infestation Drug Market Size by Application
- 5.2.1 Global Head Lice Infestation Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Head Lice Infestation Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Head Lice Infestation Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Head Lice Infestation Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Head Lice Infestation Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Head Lice Infestation Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Head Lice Infestation Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Head Lice Infestation Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Bayer
- 6.1.1 Bayer Company Information
- 6.1.2 Bayer Business Overview
- 6.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Bayer Head Lice Infestation Drug Product Portfolio
- 6.1.5 Bayer Recent Developments
- 6.2 Omega Pharma
- 6.2.1 Omega Pharma Company Information
- 6.2.2 Omega Pharma Business Overview
- 6.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Omega Pharma Head Lice Infestation Drug Product Portfolio
- 6.2.5 Omega Pharma Recent Developments
- 6.3 Thornton and Ross
- 6.3.1 Thornton and Ross Company Information
- 6.3.2 Thornton and Ross Business Overview
- 6.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Thornton and Ross Head Lice Infestation Drug Product Portfolio
- 6.3.5 Thornton and Ross Recent Developments
- 6.4 Prestige Brands
- 6.4.1 Prestige Brands Company Information
- 6.4.2 Prestige Brands Business Overview
- 6.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Prestige Brands Head Lice Infestation Drug Product Portfolio
- 6.4.5 Prestige Brands Recent Developments
- 6.5 Perrigo
- 6.5.1 Perrigo Company Information
- 6.5.2 Perrigo Business Overview
- 6.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Perrigo Head Lice Infestation Drug Product Portfolio
- 6.5.5 Perrigo Recent Developments
- 6.6 Actavis
- 6.6.1 Actavis Company Information
- 6.6.2 Actavis Business Overview
- 6.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Actavis Head Lice Infestation Drug Product Portfolio
- 6.6.5 Actavis Recent Developments
- 6.7 Reckitt Benckier
- 6.7.1 Reckitt Benckier Company Information
- 6.7.2 Reckitt Benckier Business Overview
- 6.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Reckitt Benckier Head Lice Infestation Drug Product Portfolio
- 6.7.5 Reckitt Benckier Recent Developments
- 6.8 Tyratech
- 6.8.1 Tyratech Company Information
- 6.8.2 Tyratech Business Overview
- 6.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Tyratech Head Lice Infestation Drug Product Portfolio
- 6.8.5 Tyratech Recent Developments
- 6.9 Shionogi
- 6.9.1 Shionogi Company Information
- 6.9.2 Shionogi Business Overview
- 6.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Shionogi Head Lice Infestation Drug Product Portfolio
- 6.9.5 Shionogi Recent Developments
- 6.10 TecLabs
- 6.10.1 TecLabs Company Information
- 6.10.2 TecLabs Business Overview
- 6.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 TecLabs Head Lice Infestation Drug Product Portfolio
- 6.10.5 TecLabs Recent Developments
- 6.11 Arborpharma
- 6.11.1 Arborpharma Company Information
- 6.11.2 Arborpharma Business Overview
- 6.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Arborpharma Head Lice Infestation Drug Product Portfolio
- 6.11.5 Arborpharma Recent Developments
- 6.12 Major Pharmaceuticals
- 6.12.1 Major Pharmaceuticals Company Information
- 6.12.2 Major Pharmaceuticals Business Overview
- 6.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio
- 6.12.5 Major Pharmaceuticals Recent Developments
- 6.13 Logic Products
- 6.13.1 Logic Products Company Information
- 6.13.2 Logic Products Business Overview
- 6.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Logic Products Head Lice Infestation Drug Product Portfolio
- 6.13.5 Logic Products Recent Developments
- 6.14 Tianren
- 6.14.1 Tianren Company Information
- 6.14.2 Tianren Business Overview
- 6.14.3 Tianren Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Tianren Head Lice Infestation Drug Product Portfolio
- 6.14.5 Tianren Recent Developments
- 6.15 ParaPRO
- 6.15.1 ParaPRO Company Information
- 6.15.2 ParaPRO Business Overview
- 6.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 ParaPRO Head Lice Infestation Drug Product Portfolio
- 6.15.5 ParaPRO Recent Developments
7 North America by Country
- 7.1 North America Head Lice Infestation Drug Sales by Country
- 7.1.1 North America Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Head Lice Infestation Drug Sales by Country (2021-2026)
- 7.1.3 North America Head Lice Infestation Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Head Lice Infestation Drug Market Size by Country
- 7.2.1 North America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Head Lice Infestation Drug Market Size by Country (2021-2026)
- 7.2.3 North America Head Lice Infestation Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Head Lice Infestation Drug Sales by Country
- 8.1.1 Europe Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Head Lice Infestation Drug Sales by Country (2021-2026)
- 8.1.3 Europe Head Lice Infestation Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Head Lice Infestation Drug Market Size by Country
- 8.2.1 Europe Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Head Lice Infestation Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Head Lice Infestation Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Head Lice Infestation Drug Sales by Country
- 9.1.1 Asia-Pacific Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Head Lice Infestation Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Head Lice Infestation Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Head Lice Infestation Drug Market Size by Country
- 9.2.1 Asia-Pacific Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Head Lice Infestation Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Head Lice Infestation Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Head Lice Infestation Drug Sales by Country
- 10.1.1 South America Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Head Lice Infestation Drug Sales by Country (2021-2026)
- 10.1.3 South America Head Lice Infestation Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Head Lice Infestation Drug Market Size by Country
- 10.2.1 South America Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Head Lice Infestation Drug Market Size by Country (2021-2026)
- 10.2.3 South America Head Lice Infestation Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Head Lice Infestation Drug Sales by Country
- 11.1.1 Middle East and Africa Head Lice Infestation Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Head Lice Infestation Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Head Lice Infestation Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Head Lice Infestation Drug Market Size by Country
- 11.2.1 Middle East and Africa Head Lice Infestation Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Head Lice Infestation Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Head Lice Infestation Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Head Lice Infestation Drug Value Chain Analysis
- 12.1.1 Head Lice Infestation Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Head Lice Infestation Drug Production Mode & Process
- 12.2 Head Lice Infestation Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Head Lice Infestation Drug Distributors
- 12.2.3 Head Lice Infestation Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst